NCT05746143View on ClinicalTrials.gov

The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

December 31, 2027

Conditions
Spine FusionLumbar Spine DegenerationPain, PostoperativeLumbar Spine Spondylosis
Interventions
DRUG

Zolpidem Tartrate 10 mg

two days preoperatively and five days postoperatively

DRUG

Placebo

two days preoperatively and five days postoperatively

Trial Locations (1)

90033

RECRUITING

Keck Medical Center of USC, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER